Navigation Links
New Mesothelioma Treatment Shows Promise
Date:3/22/2010

Non-toxic vaccine clinical trial, funded by the Mesothelioma Applied Research Foundation, publishes successful results for mesothelioma treatment.

(PRWEB) March 22, 2010 -- A new dendritic cell-based immunotherapy has been demonstrated in clinical trial to be well-tolerated and capable of inducing an immunological response against mesothelioma cells in patients.

In the study, funded by the Mesothelioma Applied Research Foundation and just published in the American Thoracic Society’s American Journal of Respiratory and Critical Care Medicine, researchers administered three vaccinations of clinical-grade autologous dendritic cells to ten pleural mesothelioma patients. Distinct immunological responses, with moderate fever as the only side-effect, and with no evidence of autoimmunity or severe toxicities, mark an important milestone in mesothelioma research.

“For the past several years, aggressive chemotherapy has been utilized as an often effective, but difficult-to-tolerate, drug regimen for mesothelioma treatment. The prospect of adding to our arsenal other effective, but less toxic and better-tolerated, treatments will broaden greatly our ability to treat patients,” says Mary Hesdorffer, NP, Medical Liaison for the Mesothelioma Applied Research Foundation.

Joachim G. Aerts, a co-author of the research study and pulmonary physician at Erasmus Medical Center in the Netherlands, says: “We hope that by further development of our method it will be possible to increase survival in patients with mesothelioma and eventually vaccinate persons who have been in contact with asbestos to prevent them from getting asbestos-related diseases.”

Mesothelioma is a malignant tumor of the lining of the lung, abdomen or heart caused by asbestos. Medical experts consider it one of the most aggressive of all cancers. For decades it was regarded as untreatable, deadly and hopeless; and so, in a sad, self-fulfilling prophecy, the need for research to develop effective treatments was mostly ignored. For the Mesothelioma Applied Research Foundation and today’s patients, their families, and the millions of Americans who in the last five decades have been exposed to asbestos and are at risk for the cancer, this is unacceptable.

The Mesothelioma Applied Research Foundation is the national non-profit dedicated to finding a cure for mesothelioma by funding research, providing education and support for patients, and leading advocacy efforts for a national commitment to end the mesothelioma tragedy. The Foundation hosts the annual International Symposium on Malignant Mesothelioma, which unites doctors, researchers, patients and families, legal advocates, union representatives and other concerned individuals to share information and advance mesothelioma research. For more information visit www.curemeso.org.

###

Read the full story at http://www.prweb.com/releases/2010/03/prweb3758744.htm.


'/>"/>
Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Mesocare.org Presents “Ask the Expert” for Mesothelioma Patients and Their Families
2. Sokolove Law's MesoRC Site Serves Illinois Mesothelioma Patients and their Families
3. Attorney Joe Belluck Hails Department Of Defense For Increased Funding Of Mesothelioma Research
4. Advancing Mesothelioma Research
5. Mesothelioma Clinical Trials List Offered by IQ Mesothelioma: Search Current Mesothelioma Treatment Options
6. Possible vaccine for mesothelioma proven safe
7. U.K.: Justice for Asbestos Disease Victims Requires Mesothelioma Research Funding
8. National Asbestos Lawyers of Cooney Conway Launches Mesothelioma Portal
9. Steroids May Be Overrated in Treatment of COPD
10. Experimental stem cell treatment arrests acute lung injury in mice, study shows
11. Entest BioMedical Enters into LOI with Advanced Light Devices to Develop Laser Platform for Stem Cell / Laser COPD Treatment
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
New Mesothelioma Treatment Shows Promise 
(Date:12/2/2016)... ... December 02, 2016 , ... The PAINWeekEnd Regional Conference will ... Spa in Honolulu, offering local frontline clinicians the opportunity to extend their certified ... demand for supplemental training related to pain management has surged dramatically in recent ...
(Date:12/2/2016)... ... 2016 , ... Sourced from the Isbre Springs beneath the 5,000 year old ... purity of just 6 ppm TDS (Total Dissolved Solids) in addition to its excellent ... in several ShopRite and FoodTown stores in NJ and received rave comments from consumers. ...
(Date:12/2/2016)... (PRWEB) , ... December 02, 2016 , ... Yisrayl Hawkins, ... delves into how this current generation fits into Bible Prophecy. Yisrayl says this generation, ... facts pointing to this conclusion, showing how the details line up exactly with Bible ...
(Date:12/2/2016)... ... December 02, 2016 , ... Clarify Health Solutions, Inc., ... $6.0 million in an initial round of funding. The round was led by ... caregivers can receive far better care through the application of the best technologies ...
(Date:12/2/2016)... ... December 02, 2016 , ... Today CloudMine, ... connected applications, was named the best Sales Team of 2016 as part of ... made today by the Software & Information Industry Association (SIIA), the principal trade ...
Breaking Medicine News(10 mins):
(Date:12/2/2016)... 2016   CytoSorbents Corporation (NASDAQ: CTSO ... Union approved CytoSorb ® cytokine adsorber to treat ... announced that Dr. Phillip Chan , Chief Executive ... Micro Main Event investor conference held from December ... Sunset Boulevard Hotel in Los Angeles, California ...
(Date:12/2/2016)... 2016 On Thursday, the NASDAQ Composite ... Jones Industrial Average edged 0.36% higher, to finish at 19,191.93; ... were broad based as six out of nine sectors ended ... on the following Services equities: Myriad Genetics Inc. (NASDAQ: ... INC Research Holdings Inc. (NASDAQ: INCR ), and ...
(Date:12/2/2016)... Dec. 1, 2016 The concept of rare diseases ... given to this sector has been taking shape in ... the political aspects and initiatives related to orphan medicinal products ... the level of member states individually. Many member states in ... the space of orphan medicinal products, the result of which ...
Breaking Medicine Technology: